1. Home
  2. News
  3. Shanghai InnoStar Bio-tech Co. Ltd.
  4. Announcement on Convening the Q3 2024 Performance Briefing
More Shanghai InnoStar Bio-tech Co. Ltd. news
Shanghai InnoStar Bio-tech Co. Ltd.SSE: 688710

Announcement on Convening the Q3 2024 Performance Briefing

Nov 5, 2024 · Issued by Shanghai InnoStar Bio-tech Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Nov 5, 2024 · 3 pages · Chinese

On 6ix: 6ix.com/news/announcement-on-convening-the-q3-2024-performance-briefing-479

Shanghai InnoStar Bio-tech Co. Ltd. on 6ix

Earlier from Shanghai InnoStar Bio-tech

  • Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2024Nov 1, 2024
  • Announcement on Using Raised Funds to Increase Capital and Provide Loans to Wholly-owned Subsidiaries for Implementation of Investment Projects Financed by Raised FundsOct 30, 2024
  • Announcement on Renewing Engagement of Accounting FirmOct 16, 2024

Later from Shanghai InnoStar Bio-tech

  • Announcement on Completing Industrial and Commercial Change Registration and Obtaining Renewed Business LicenseNov 20, 2024
  • Announcement on Resolution of the 9th Meeting of the 3rd Board of SupervisorsNov 30, 2024
  • Announcement on Resolution of the 4th Extraordinary General Meeting in 2024Dec 25, 2024
  • Notice on Convening the 1st Extraordinary General Meeting in 2025Jan 11, 2025
  • Announcement on Resolution of the 1st Extraordinary General Meeting in 2025Feb 8, 2025
All Shanghai InnoStar Bio-tech news releases↗

Follow Shanghai InnoStar Bio-tech into a list and get an email when it puts out news.

Follow Shanghai InnoStar Bio-tech
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer